SCHEMBL1004272

SCHEMBL1004272

COc1cccc(CC2CCc3cc(C(=O)O)[nH]c32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.44
CYP24A1 Q07973 3/20 0.44
CYP26A1 O43174 2/20 0.44
MMP1 P03956 2/20 0.44
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
MMP12 P39900 2/20 0.44
EED O75530 1/20 0.43
CYP19A1 P11511 2/20 0.42
CHRM4 P08173 2/20 0.41
DRD2 P14416 2/20 0.41
HTR7 P34969 2/20 0.41
MAPKAPK2 P49137 1/20 0.41
CYP1A2 P05177 1/20 0.41
APEX1 P27695 1/20 0.41
HTR1A P08908 1/20 0.41
SLC6A4 P31645 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003764 0.91 MMP1 (0.45) PPARDCYP24A1CYP26A1MMP1MMP2
SCHEMBL1003795 0.84 DDB1 (0.46) CYP26A1CYP19A1
SCHEMBL12777444 0.84 DDB1 (0.46) CYP26A1CYP19A1
SCHEMBL1006648 0.83 ESR1 (0.56) CYP26A1CYP19A1
SCHEMBL1004266 0.83 MMP1 (0.43) PPARDMMP1MMP2MMP9MMP12
SCHEMBL1002980 0.82 ESR1 (0.40) MMP1MMP2MMP9MMP12CHRM2
SCHEMBL1005081 0.82 CNR2 (0.44) MMP1MMP2MMP9MMP12
SCHEMBL1003759 0.79 ESR1 (0.51) CYP24A1CYP26A1CYP19A1
SCHEMBL1004115 0.78 MMP2 (0.41) MMP1MMP2MMP9MMP12CHRM2
SCHEMBL2076153 0.78 POLB (0.44) MMP1MMP2MMP9MMP12APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE PPARD 3845/4885CYP24A1 3426/4885CYP26A1 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.